Manon Benders
Manon Benders Dr Manon BendersPediatrician-neonatologistWilhelmina Children’s Hospital, UMC Utrecht (The Netherlands) Session: From pre-clinical work to an approved therapy – Wednesday 14 May (10.30am-12pm) Manon Benders is a neonatologist with an interest in neonatal neurology. She is Professor in Neonatology at the Wilhelmina Children’s Hospital, UMC Utrecht. Her work focuses on improving long-term outcomes in high-risk newborns by translating scientific discoveries into clinical care. She has extensive experience in both clinical and academic settings, including positions in Geneva and London, where she contributed to advancing neonatal brain research. She coordinates several (inter)national research projects aimed at developing neuroprotective and regenerative strategies for the vulnerable neonatal brain. She is known for integrating advanced imaging, biomarker research, and cell-based therapies to better understand and treat neonatal brain injury. In addition to her research, she actively supervises PhD students and clinical fellows, fostering the next generation of clinician-scientists. Through her translational approach, she…
Daan Ophelders
Daan Ophelders Dr Daan OpheldersAssistant Professor, Laboratory of PediatricsMaastricht University (The Netherlands) Session: Learnings from co-creation: involving external stakeholders in research – Thursday 15 May (8.30-10am)
Caroline de Theije
Caroline de Theije Dr Caroline de TheijeAssistant ProfessorUMC Utrecht (The Netherlands) Session: Alternatives and adjuncts to stem cells – Wednesday 14 May (3.30-5pm) Caroline de Theije is Assistant Professor at the Department for Developmental Origins of Disease at University Medical Center Utrecht, The Netherlands. She has a background in medical biology. She graduated from the Utrecht University with a PhD in Nutritional Neuroscience and focused her PhD and postdoc research on the effects of cell-based and nutrition-based therapies to enhance postnatal neurodevelopment. Her current research focusses on the potency of cell-derived and milk-derived extracellular vesicles to treat neonatal brain injury and investigates the underlying therapeutic mechanisms.
Martina Gabrielli
Martina Gabrielli Dr Martina GabrielliResearch FellowNational Research Council of Italy (CNR) Institute of Neuroscience (Italy) and currently at Nottingham Trent University (UK) Session: In vitro studies of stem cell activities – Thursday 15 May (10.30am-12pm) Martina Gabrielli is currently a Research Fellow at Nottingham Trent University (UK) and recipient of a BBSRC Fellowship (UKRI) for future leaders in research, to study the molecular basis of cognitive decline in brain ageing. After a BSc and MSc in Medical Biotechnology and a PhD in Pharmacological Sciences at the University of Milan, she worked for many years in Dr Claudia Verderio’s laboratory at the CNR Institute of Neuroscience (Italy), where she explored the role of extracellular vesicles (EVs) released by glial cells in brain health and disease with a particular focus on their effects on neuronal function and inflammation. She was awarded a FISM fellowship and a Veronesi Foundation Travel Grant Fellowship to…
Tamara Yawno-Fegan
Tamara Yawno-Fegan Dr Tamara Yawno-FeganSenior Research FellowHudson Institute of Medical Research and Monash University (Australia) Session: Using large animal translational models and how to do it better – Wednesday 14 May (8.30-10am) Tamara Yawno is a renowned developmental neuroscientist with over 17 years of experience investigating neurodevelopment in large animal models of cerebral palsy. Her exceptional translational research includes ground-breaking work on ganaxolone for neonatal seizures, which is now part of a multi-centre collaboration to trial ganaxolone against standard therapy in newborns with hypoxic ischemic encephalopathy. Tamara’s recent research focuses on the role of placental stem cells in brain development and their neuroprotective actions in compromised pregnancies. A key aspect of her work involves extracellular vesicles (EVs), bioactive particles secreted by placental stem cells. Containing proteins, lipids, and RNA, EVs show potential as therapeutic agents. Tamara’s studies suggest that EVs may promote neuroprotection in the developing brain, offering a promising…
Cindy Bokobza
Cindy Bokobza Dr Cindy BokobzaHead Scientist at MayInserm U1141 (France) Session: From pre-clinical work to an approved therapy – Wednesday 14 May (10.30am-12pm) Cindy Bokobza is a perinatal neuroscientist and head scientist at May, a mission-driven health tech startup. She has a background in translational research, with experience in France, the USA, and Portugal. Cindy coordinated key projects within the PREMSTEM consortium and has led multiple studies on neonatal brain injury, neuroinflammation, and early neurodevelopment. She has supervised over 15 students and received awards including the Alzheimer Harmonie Mutuelle Prize and the ARAPI Young Researcher Award. Passionate about bridging science and real-world health impact, she now focuses on evaluating and scaling digital health tools to support maternal and infant well-being.
William Dawes
William Dawes Dr William DawesAcademic Paediatric NeurosurgeonConsultant Paediatric Neurosurgeon, Oxford University Hospital (UK); Honorary Associate Professor, Institute of Child Health, University College London (UK) Session: Learnings from co-creation: involving external stakeholders in research – Thursday 15 May (8.30-10am) William Dawes is an academic paediatric neurosurgeon from Oxford University Hospital. He was awarded his PhD from Queen Mary University of London in 2017 and became a Fellow of the Royal College of Surgeons in Surgical Neurology in 2018. His PhD thesis focused on role of neural stem cells as potential therapeutic targets following germinal matrix/intraventricular haemorrhage in neonates born prematurely. William is an Honorary Associate Professor at UCL Institute of Child Health and Co-investigator and lead for basic sciences on the NIHR funded ENLIVEN Trial, a UK-based national clinical trial investigating the efficacy of endoscopic intraventricular washout following NIVH. His current research is exploring the role of the ependymal lining of…
András Lakatos
András Lakatos Dr András LakatosAssociate Professor of Neurobiology and Neurology Department of Clinical Neurosciences, University of Cambridge Session: Novel and innovative approaches to screening – Tuesday 13 May (2-3.30pm) András Lakatos is Associate Professor of Neurology and Neurobiology at the University of Cambridge and leads a research laboratory in the Department of Clinical Neurosciences. Over the past 10 years, he and his team have pioneered the development of human 3D neural organoid and other stem cell-based models. This work helped uncover novel cellular and molecular mechanisms relevant to the healthy, injured, and diseased central nervous system, aiming to identify new neurological treatment strategies. He has additional affiliations with the MRC-Wellcome Trust Cambridge Stem Cell Institute and Cambridge University Hospitals, where he conducts his clinical practice as a consultant neurologist. He has received several prestigious awards, including the MRC Clinician Scientist Fellowship Award in 2017, the Alzheimer’s Research UK David Hague…
Md Munnaf Hossen
Md Munnaf Hossen Md Munnaf HossenPhD candidate, School of Health and Biomedical SciencesRMIT University (Australia) Session: Cell based therapies in animal studies – Wednesday 14 May (1.30-3pm) Md Munnaf Hossen is a PhD candidate at RMIT University, Australia working with Dr Rosita Zakaria and Dr Bobbi Fleiss. He is investigating the effects of perinatal brain injury on glial cell responses and kynurenine pathway metabolites. His multidisciplinary approach integrates immunohistochemistry, LC-MS/MS, and RNA sequencing to elucidate the molecular and cellular pathways underlying neuroinflammatory responses. Recently, Munnaf was awarded a competitive research grant by the Australian Institute of Medical Scientists (AIMS) to support the development of a novel LC-MS/MS approach for analysing multiple kynurenine pathway metabolites. His work aims to advance our understanding of early life neuroinflammatory processes and inform future strategies for brain injury prevention and neurodevelopmental health.
Jessica Dubois
Jessica Dubois Dr Jessica DuboisResearcher Inserm, NeuroDiderot unit, NeuroSpin center (France) Session: Imaging modalities – Thursday 15 May (12.30-2pm) Jessica Dubois has been a researcher in neuroscience at Inserm (France) since 2009. She heads the inDEV team (Imaging of Neurodevelopmental Phenotypes) at the NeuroDiderot unit, between the Robert-Debré paediatric hospital (Paris) and the NeuroSpin center (Saclay). Her research focuses on the early development of the human brain, studied using neuroimaging and behavioural evaluations in infants. She has an engineering background (Ecole Centrale Paris) and a PhD in Physics (Université Paris Sud). She carried out her postdoctoral research with Professor P.S. Hüppi at the University Hospitals of Geneva, Switzerland, where she studied early cortical folding in premature newborns. Her current projects focus on sensorimotor development, in typical and pathological conditions, particularly in infants at high risk of neurodevelopmental disorders and cerebral palsy. She has made significant contributions to our understanding of…